Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
ACS Appl Bio Mater ; 7(5): 3050-3060, 2024 05 20.
Artigo em Inglês | MEDLINE | ID: mdl-38598772

RESUMO

Peptides are a promising skincare ingredient, but due to their inherent instability and the barrier function of the skin's surface, they often have limited skin absorption and penetration, which can significantly hinder their skincare benefits. To address this, a novel technique called NanoGlow has been introduced for encapsulating peptide-based cosmetic raw materials into engineered nanosized plant-derived exosomes (pExo) to achieve the goal of a healthier and more radiant skin state. In this approach, pExo served as carriers for cosmetic peptides across the intact skin barrier, enhancing their biological effectiveness in skin beauty. The NanoGlow strategy combines chemical activation and physical proencapsulation, boasting a high success rate and straightforward and stable operation, making it suitable for large-scale production. Comprehensive analysis using in vitro cellular absorption and skin penetration models has demonstrated that the nanosized pExo carriers significantly improve peptide penetration into the skin compared to free peptides. Furthermore, in vivo tissue slice studies have shown that pExo carriers efficiently deliver acetyl hexapeptide-8 to the skin's dermis, surpassing the performance of free peptides. Cosmetic skincare effect analysis has also indicated that pExo-loaded cosmetic peptides deliver superior results. Therefore, the NanoGlow technique harnesses the natural size and properties of pExo to maximize the bioavailability of cosmetic peptides, holding great promise for developing advanced peptide delivery systems in both the cosmetic and medical drug industries.


Assuntos
Materiais Biocompatíveis , Cosméticos , Exossomos , Peptídeos , Exossomos/química , Exossomos/metabolismo , Cosméticos/química , Peptídeos/química , Peptídeos/administração & dosagem , Materiais Biocompatíveis/química , Humanos , Teste de Materiais , Tamanho da Partícula , Pele/metabolismo , Animais , Sistemas de Liberação de Medicamentos , Plantas/química , Plantas/metabolismo , Absorção Cutânea , Portadores de Fármacos/química
2.
Eur J Med Chem ; 121: 232-237, 2016 Oct 04.
Artigo em Inglês | MEDLINE | ID: mdl-27240277

RESUMO

Enfuvirtide (ENF) is a clinically used peptide drug for the treatment of HIV infections, but its poor pharmacokinetic profile (T1/2 = 1.5 h in rats) and low aqueous solubility make the therapy expensive and inconvenience. In this study, we present a simple and practical strategy to address these problems by conjugating ENF with polyethylene glycol (PEG). Site-specific attachment of a 2 kDa PEG at the N-terminus of ENF resulted in an ENF-PEG (EP) conjugate with high solubility (≥3 mg/mL) and long half-life in rats (T1/2 = 16.1 h). This conjugate showed similar antiviral activity to ENF against various primary HIV-1 isolates (EC50 = 6-91 nM). Mechanistic studies suggested the sources of the antiviral potency. The conjugate bound to a functional domain of the HIV gp41 protein in a helical conformation with high affinity (Kd = 307 nM), thereby inhibiting the gp41-mediated fusion of viral and host-cell membranes. As PEG conjugation has advanced many bioactive proteins and peptides into clinical applications, the EP conjugate described here represents a potential new treatment for HIV infections that may address the unmet medical needs associated with the current ENF therapy.


Assuntos
Proteína gp41 do Envelope de HIV/farmacocinética , Inibidores da Fusão de HIV/farmacocinética , Fragmentos de Peptídeos/farmacocinética , Animais , Antivirais/química , Antivirais/farmacocinética , Enfuvirtida , Proteína gp41 do Envelope de HIV/química , Inibidores da Fusão de HIV/química , Infecções por HIV/tratamento farmacológico , HIV-1/efeitos dos fármacos , Meia-Vida , Fragmentos de Peptídeos/química , Polietilenoglicóis/química , Polietilenoglicóis/farmacologia , Ratos , Solubilidade
4.
Chin Med J (Engl) ; 126(20): 3891-6, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24157152

RESUMO

BACKGROUND: Olfactory ensheathing cell (OEC) transplantation is a promising or potential therapy for spinal cord injury (SCI). However, the effects of injecting OECs directly into SCI site have been limited and unsatisfied due to the complexity of SCI. To improve the outcome, proper biomaterials are thought to be helpful since these materials would allow the cells to grow three-dimensionally and guide cell migration. METHODS: In this study, we made a new peptide hydrogel scaffold named GRGDSPmx by mixing the pure RADA16 and designer peptide RADA16-GRGDSP solution, and we examined the molecular integration of the mixed nanofiber scaffolds using atomic force microscopy. In addition, we have studied the behavior of OECs in GRGDSPmx condition as well as on RADA16 scaffold by analyzing their phenotypes including cell proliferation, apoptosis, survival, and morphology. RESULTS: The experimental results showed that GRGDSPmx could be self-assembled to form a hydrogel. Inverted optical microscopic and scanning electron microscopic analyses showed that OECs are viable and they proliferate within the nanostructured environment of the scaffold. Thiazolyl blue (MTT) assay demonstrated that OEC proliferation rate was increased on GRGDSPmx scaffold compared with the pure RADA16 scaffold. In addition, OECs on GRGDSPmx scaffolds also showed less apoptosis and maintained the original spindle-shaped morphology. Calcein-AM/PI fluorescence staining revealed that OECs cultured on GRGDSPmx grew well and the viable cell count was 95%. CONCLUSION: These results suggested that this new hydrogel scaffold provided an ideal substrate for OEC three-dimensional culture and suggested its further application for SCI repair.


Assuntos
Hidrogel de Polietilenoglicol-Dimetacrilato/química , Bulbo Olfatório/citologia , Peptídeos/química , Engenharia Tecidual/métodos , Alicerces Teciduais/química , Animais , Proliferação de Células , Células Cultivadas , Imuno-Histoquímica , Masculino , Microscopia de Força Atômica , Microscopia Confocal , Ratos , Ratos Sprague-Dawley
5.
Nanoscale ; 4(11): 3475-81, 2012 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-22572999

RESUMO

A high-efficiency photoelectrode for dye-sensitized solar cells (DSSCs) should combine the advantageous features of fast electron transport, slow interfacial electron recombination and large specific surface area. However, these three requirements usually cannot be achieved simultaneously in the present state-of-the-art research. Here we report a simple procedure to combine the three conflicting requirements by using porous SnO(2) nanotube-TiO(2) (SnO(2) NT-TiO(2)) core-shell structured photoanodes for DSSCs. The SnO(2) nanotubes are prepared by electrospinning of polyvinyl pyrrolidone (PVP)/tin dichloride dihydrate (SnCl(2)·2H(2)O) solution followed by direct sintering of the as-spun nanofibers. A possible evolution mechanism is proposed. The power conversion efficiency (PCE) value of the SnO(2) NT-TiO(2) core-shell structured DSSCs (∼5.11%) is above five times higher than that of SnO(2) nanotube (SnO(2) NT) DSSCs (∼0.99%). This PCE value is also higher than that of TiO(2) nanoparticles (P25) DSSCs (∼4.82%), even though the amount of dye molecules adsorbed to the SnO(2) NT-TiO(2) photoanode is less than half of that in the P25 film. This simple procedure provides a new approach to achieve the three conflicting requirements simultaneously, which has been demonstrated as a promising strategy to obtain high-efficiency DSSCs.


Assuntos
Corantes/química , Nanotubos/química , Energia Solar , Compostos de Estanho/química , Titânio/química , Eletrodos , Povidona/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA